Srx Health Solutions Inc

Srx Health Solutions Inc exhibits a capital structure with a high debt-to-equity ratio of 4.64, indicating a significant reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.02, suggesting limited short-term liquidity cushion. Despite holding $3.88 million in cash and equivalents, the company's long-term debt of $5.23 million and negative operating cash flow of $1.01 million raise concerns about its ability to meet long-term obligations.

Profitability metrics reveal a challenging financial position. The company reported a net loss of $2.83 million and an operating loss of $2.47 million, with a return on equity of -2.51% and a return on assets of -0.18%. These figures fall significantly below the industry's median profitability metrics, indicating underperformance relative to peers.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to market-specific risks and limits the ability to offset regional downturns.

Growth trajectory is negative, with the company reporting a decline in operating cash flow and a net loss in the latest period. The absence of disclosed revenue growth or expansion plans suggests limited near-term upside potential.

The company faces moderate liquidity risk due to its negative operating cash flow and high debt load. While dilution risk is currently low, the company's capital structure and financial performance could necessitate future equity issuance, potentially diluting existing shareholders.

Recent filings and transcripts indicate ongoing financial challenges, with the company reporting a net loss and negative cash flow. No material strategic developments or operational improvements were disclosed in the latest available documents.

Srx Health Solutions Inc (SRXH.K) has recorded its first analysis, establishing a baseline for future monitoring as no prior data exists for delta computation. This initial snapshot reveals a notable addition to the company's shareholder registry, marking a specific point of interest for investors tracking early-stage capital movements. The primary signal detected is a new holder addition as of June 30, 2024. An investor identified by ID 466 acquired a position of 56 shares, valued at approximately $0.000218 million. This transaction represents a weight of roughly 4.94e-09 percent of the total equity, indicating a micro-scale entry into the company's capital structure. Despite this new holder activity, the broader institutional landscape remains sparse. The company currently reports zero analyst coverage and zero index memberships, suggesting limited visibility in mainstream financial markets. Furthermore, the officer count is listed as zero, which may reflect data reporting limitations or the specific corporate structure at the time of this initial analysis. The significance of this development lies in the establishment of a foundational data point for SRXH.K. With six top holders now identified and the first holder change logged, the company has moved from an unanalyzed state to one with observable, albeit minimal, shareholder activity. This baseline allows for the tracking of future accumulation or distribution trends, though the current scale of investment remains negligible in terms of total market value. [doc:srxh.k-ha-financials]

SRXH reduced long-term debt significantly from $11.4 million in 2023 to $2.4 million in 2025, improving its balance sheet.

The company achieved a positive operating income of $239,000 in fiscal year 2025, marking a return to operational profitability.

SRXH maintained a current ratio of 2.29 as of September 2025, indicating adequate short-term liquidity to cover liabilities.

Dilution risk is assessed as low, suggesting limited immediate threat to existing shareholder equity value from share issuance.

Capital expenditure relative to revenue was above the 75th percentile of the Food Processing cohort, indicating efficient capital usage.

The company reported a massive net loss of $45.1 million in the latest period, drastically worsening profitability metrics.

SRXH faces high credit risk and carries a high leverage band with a debt-to-equity ratio of 19.64.

Operating and net margins are in the bottom quartile of the Food Processing cohort, indicating poor competitive positioning.

Free cash flow deteriorated sharply to a negative $8.6 million, highlighting significant cash burn and liquidity pressure.

Revenue $35.0M, −9,4% YoY; Operating income +101,1% YoY.

• ▍Revenue $35.0M, −9,4% YoY
• ▍Operating income +101,1% YoY
• ▍Net income +99,3% YoY
• ▍Free cash flow +99,6% YoY
• ▍Net margin -0.5%

Revenue $38.6M, −29,4% YoY; Operating income +45,4% YoY.

• ▍Revenue $38.6M, −29,4% YoY
• ▍Operating income +45,4% YoY
• ▍Net income +42,1% YoY
• ▍Free cash flow +44,2% YoY
• ▍Net margin -59.0%

Revenue $54.7M, +18,8% YoY; Operating income −130,6% YoY.

• ▍Revenue $54.7M, +18,8% YoY
• ▍Operating income −130,6% YoY
• ▍Net income −1 260,8% YoY
• ▍Free cash flow −916,0% YoY
• ▍Net margin -71.9%

Revenue $46.0M; Operating income -$16.8M.

• ▍Revenue $46.0M
• ▍Operating income -$16.8M
• ▍Net margin 7.4%